Status:
RECRUITING
A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
Lead Sponsor:
Ruijin Hospital
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
This study is to clarify the distribution characteristics, host and clinical characteristics, disease outcome and risk factors, changes of multiple organs such as cardiopulmonary function and changes ...
Eligibility Criteria
Inclusion
- SARS-Cov-2-RNA positive
- informed consent signed
Exclusion
- informed consent rejected
Key Trial Info
Start Date :
March 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2032
Estimated Enrollment :
250000 Patients enrolled
Trial Details
Trial ID
NCT05387304
Start Date
March 29 2022
End Date
May 31 2032
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, China